Joke Mm den Haan

17PUBLICATIONS
108CO-AUTHORS
Cancer cell biologyEpigenetics (incl. genome methylation and epigenomics)Innate immunityMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 28, 2026
MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growth.

|Mar 18, 2026
Histone methyltransferase DOT1L differentially affects the development of dendritic cell subsets.

Rianne G Bouma, Willem-Jan de Leeuw, Aru Z Wang

|Feb 23, 2026
B cells maintain the homeostasis of splenic marginal zone antigen-presenting cells to promote the antiviral CD8+ T-cell response.

Xinyuan Liu, Filiz Demircik, Mariia Antipova

|May 07, 2025
Multi-Epitope DC Vaccines with Melanoma Antigens for Immunotherapy of Melanoma.

Athanasios Seretis, Lukas Amon, Christoph H Tripp

|Apr 23, 2025
Exploring CD169+ Macrophages as Key Targets for Vaccination and Therapeutic Interventions.

Rianne G Bouma, Aru Z Wang, Joke M M den Haan

|Nov 08, 2024
Development of a Versatile Cancer Vaccine Format Targeting Antigen-Presenting Cells Using Proximity-Based Sortase A-Mediated Ligation of T-Cell Epitopes.

Aru Z Wang, Hendrik J Brink, Rianne G Bouma

Pageof 3

Frequent Collaborators

3 joint publications

Alsya J Affandi

2 joint publications

Fred van Leeuwen

2 joint publications

Dieke van Dinther

1 joint publications

Jip T van Dinter